Our Team.
Accelerating nucleic acid therapeutics
Our Mission
To develop nucleic acid therapeutics, through a blend of proprietary chemistry and novel biology, to solve unmet medical needs and improve lives.
About Us
Cargene is a preclinical-stage biopharmaceutical company developing oligonucleotide therapeutics across a broad range of diseases and targeting a variety of organs and tissues.
With sites in Singapore, China and USA, Cargene leverages our chemistry and biological insights to deliver clinically meaningful treatments.
